INQUIRIES MAY BE MADE TO HARVARD MEDICAL SCHOOL Department of Continuing Education

 

Phone: 617-384-8600 (Monday to Friday - 9:00 am to 5:00 pm EST)

Email: CEPrograms@hms.harvard.edu

FACULTY PROFILES

COURSE DIRECTOR

Lawrence E. Lifson, MD

 

Lawrence E. Lifson, MD, is a Lecturer on Psychiatry, Harvard Medical School. He is the Director of the Continuing Education Program at Beth Israel Deaconess Medical Center and is a faculty member at Boston Psychoanalytic Society and Institute. He is a co-chair for Continuing Education Program at Boston Psychoanalytic Society and Institute. Dr. Lifson is a Distinguished Life Fellow of the American Psychiatric Association and the 2012 recipient of the Massachusetts Psychiatric Society’s “Outstanding Psychiatrist in Education Award”. He is the 2016 Recipient of Tufts Medical Alumni Association Dean’s Award and has received the 2018 American Psychoanalytic Association Edith Sabshin Teaching Award. He is editor of Understanding Therapeutic Action: Current Concepts of Cure and The Mental Health Practitioner and the Law and The Psychology of Investing.

 

 

WEEKEND SEMINARS Faculty

 

Ross J. Baldessarini, MD, DSc (hon.)

Clinical Psychopharmacology: A Master Class

 

Ross J. Baldessarini, MD, DSc (hon.) is a Professor of Psychiatry and in Neuroscience at Harvard Medical School and Director of the Psychopharmacology Program and International Consortium for Bipolar Disorder Research at McLean Hospital. Dr. Baldessarini is the recipient of many regional, national, and international research, mentoring, and teaching awards, and is on the Institute of Scientific Information list of most-cited authors in pharmacology and psychiatry. He has authored over 2300 scientific articles and several books, including Chemotherapy in Psychiatry, third edition. He also wrote the chapters on psychopharmacology for the standard American textbook of pharmacology, Goodman and Gilman’s Pharmacologic Basis of Therapeutics for several decades, and serves on editorial boards of leading journals in pharmacology and psychiatry.

 

 

David Treadway, PhD

Treating Couples Well: A Model for Creating Collaborative Couples Treatment

 

David Treadway, PhD is a nationally known therapist and author who has been giving workshops and trainings around the country for the past thirty years. He is the co-author of Home Before Dark: A Family Portrait of Cancer and Healing. His previous books are Intimacy, Change, and other Therapeutic Mysteries: Stories of Clinicians and Clients, Dead Reckoning: A Therapist Confronts his own Grief and Before It’s Too Late: Working with Substance Abuse in the Family. He is the author of over thirty articles and is a 2002 Psychotherapy Networker award winner for an article selected as one of the best ten pieces in their 25 year history. Dr Treadway has appeared on Good Morning America, 20/20 and other television shows as well as hosting his own radio program on family communications.

 

Tim Havens, MD

Organizations and Leadership: Diagnosis and Treatment

 

Tim Havens, MD is a Lecturer on Psychiatry at Harvard Medical School and Senior Vice President of the Levinson Institute. He has held many medical leadership roles, and directs the Harvard Medical School, Beth Israel Deaconess Medical Center program on Leadership for Physician Executives. He has written about effective organizational leadership and lectures extensively on leadership development, managing organizational change, executive coaching, and building effective management teams.

 

WEEK-Long SEMINARS Faculty

 

Charles Nemeroff, MD, PhD

Psychopharmacology: A Master Class

Charles Nemeroff, MD, PhD is Leonard M. Miller Professor and Chairman in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine. He is the past President of the American College of Psychiatrists, International Society of Psychoneuroendocrinology and the American College of Neuropsychopharmacology. Dr. Nemeroff is a member of the Institute of Medicine. He is the author of over 1000 scientific articles and book chapters. He is also editor of Management of Treatment –Resistant Major Psychiatric Disorders and Co-editor Essentials of Clinical Psychopharmacology and The Bipolar Book: History, Neurology and Treatment.

 

 

Susan M. Pollak, EdD, MTS

 

Meditation and Mindfulness in Clinical Practice: Enhancing Treatment Effectiveness and Personal Wellbeing

 

Susan M. Pollak, MTS, Ed.D is co-founder, senior teacher and advisor at the Center for Mindfulness and Compassion, Cambridge Health Alliance, Harvard Medical School. Dr. Pollak is the President of the Institute for Meditation and Psychotherapy. She is the co-editor of The Cultural Transition; contributing author to Mapping the Moral Domain; Evocative Objects; and Mindfulness and Psychotherapy. Dr. Pollak is co-author, with Thomas Pedulla and Ronald Siegel, of Sitting Together: Essential Skills for Mindfulness-Based Psychotherapy.

 

 

 

Carl Salzman, MD

 

Essential Psychopharmacology, 2018: Practice and Update

 

Carl Salzman, MD is a Professor of Psychiatry, Harvard Medical School, Beth Israel Deaconess Medical Center. He has served as Chairman, American Psychiatric Association Benzodiazepine Task Force. He has been awarded the Elvin V. Semrad Award for Outstanding Teaching in Psychiatry at the Massachusetts Mental Health Center, Vestermark Award from the American Psychiatric Association for Outstanding Contribution to Psychiatric Education, Heinz E. Lehmann Award from the New York State Department of Mental Hygiene for his contribution to psychiatric research, Teacher of the Year Award from CME and “Outstanding Psychiatrist Award for Education” by the Massachusetts Psychiatric Society. He has also been on numerous editorial boards including The American Journal of Psychiatry. Dr. Salzman is author of over 300 publications and 7 books including Clinical Geriatric Psychopharmacology, 4th edition.

 

 

Alan I. Green, MD

 

Essential Psychopharmacology, 2018: Practice and Update

 

Alan I. Green, MD is the Raymond Sobel Professor of Psychiatry, Professor of Molecular and Systems Biology, Chairman of the Department of Psychiatry at the Geisel School of Medicine at Dartmouth, and Director, Dartmouth Clinical and Translational Science Institute. An internationally recognized translational investigator in the clinical neuropharmacology of schizophrenia and substance abuse, Dr. Green is currently the Principal Investigator of two NIH grants. He has published nearly 200 scientific articles and has received numerous awards, including the “Outstanding Psychiatrist Award for Research” from the Massachusetts Psychiatric Society and the “Outstanding Teaching Award” at the Brocton VA Medical Center.

 

Russell G. Vasile, MD

 

Essential Psychopharmacology, 2018: Practice and Update

Emerging Strategies in the Assessment and Treatment of Depression and Anxiety: Integrating Psychopharmacology and Psychotherapy

 

Russell G. Vasile, MD is an Associate Professor of Psychiatry, Harvard Medical School and Director of the Affective Disorders Consultation Program at the Beth Israel Deaconess Medical Center. Dr. Vasile has published in diverse areas related to the assessment and treatment of anxiety and affective disorders. Dr. Vasile is also a graduate of the Boston Psychoanalytic Society and Institute. He is a past recipient of the Elvin V. Semrad Award for Excellence in Teaching at the Massachusetts Mental Health Center.

 

Roscoe O. Brady Jr. MD, PhD

 

Essential Psychopharmacology, 2018: Practice and Update

 

Roscoe Brady Jr. MD, PhD is an Assistant Professor in the Department of Psychiatry at Harvard Medical School and Director of Psychopharmacology Education at the Beth Israel Deaconess Medical Center. He is also the director of the Research Concentration in the Beth Israel Deaconess Medical Center Harvard Psychiatry Residency Training Program. He is the recipient of the Jonathan F. Borus Outstanding Early Educator Award at Harvard Medical School. His academic interests include mood state switching in bipolar disorder and he is the Principal Investigator of a NIH funded longitudinal neuroimaging study.

 

 

Barbara J. Coffey, MD, MS

Essential Psychopharmacology, 2018: Practice and Update

 

Barbara Coffey, MD, MS is Division Chief, Child and Adolescent Psychiatry, and Professor, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine. Associate Editor, Advanced Pediatric Psychopharmacology; Dr. Coffey is a former Director of the Tics and Tourette’s Clinics at McLean and Massachusetts General Hospital, and former Director of Pediatric Psychopharmacology at McLean Hospital. She is an Associate Editor, Advanced Pediatric Psychopharmacology and Journal of Child and Adolescent Psychopharmacology.

 

Robert M. Goisman, MD

 

The Widening Scope of Cognitive-Behavioral Therapy

 

Robert M. Goisman, MD is an Associate Professor of Psychiatry (part-time) at Harvard Medical School, Beth Israel Deaconess Medical Center and the former Director of Medical Student Education at Massachusetts Mental Health Center. His research interests have included behavioral therapy, anxiety disorders, and psychosocial rehabilitation in chronic mental illness. Dr. Goisman is a past recipient of the Elvin V. Semrad Award for Excellence in Teaching at the Massachusetts Mental Health Center. He is a past recipient of the “Outstanding Psychiatrist Award” from the Massachusetts Psychiatric Society for Public Sector Service. He is a Founding Fellow of the Academy of Cognitive Therapy, a Distinguished Life Fellow of the American Psychiatric Association, and a Fellow of the Association for Behavioral and Cognitive Therapies. In 2011 he received the Special Faculty Prize for Sustained Excellence in Teaching from Harvard Medical School.

 

Matcheri S. Keshavan, MD

 

The Widening Scope of Cognitive-Behavioral Therapy

 

Matcheri S. Keshavan, MD is Stanley Cobb Professor of Psychiatry, Department of Psychiatry, Harvard Medical School and Vice Chair, Public Psychiatry, Department of Psychiatry, Beth Israel Deaconess Medical Center.

 

Daniel Brown, PhD, ABPH

 

Complex Psychological Trauma and Recovery

 

Daniel Brown, PhD, ABPH is an Associate Professor of Psychology, part time, Harvard Medical School, Beth Israel Deaconess Medical Center. He is the author of 15 books including two on developmental psychopathology, Human Feelings and Transformation of Consciousness and Attachment Disturbances in Adults: Treatment for Comprehensive Repair.

John Ratey, MD

 

A New Prescription on 2018: Exercise and other Medical and Complementary Ground Breaking Techniques for the Treatment of ADHD, Aggressions and Autism Spectrum Disorders

 

John J. Ratey, MD is an Associate Professor of Psychiatry, part time, Harvard Medical School, Beth Israel Deaconess Medical Center. Dr. Ratey has been a leading teacher and researcher on brain and personality and treatment of aggression and the development of disabilities as well as the psychological and cognitive benefits of exercise and play. He has written extensively on Attention Deficit Disorder, learning disabilities, brain differences that affect social skills and has published Shadow Syndromes, a book that has helped broaden our understanding of how the brain affects everyday life. Dr. Ratey is the author of co-author of more than 85 scientific publications and eight books including Driven to Distraction and The User’s Guide to the Brain and Spark: The New Revolutionary Science of Exercise and the Brain and Go Wild: Free Your Body and Mind From the Afflictions of Civilization.

 

Ronald Siegel, PsyD

 

Mindfulness: Inside and Outside the Clinical Hour

 

Ronald D. Siegel, PsyD, is an Assistant Professor of Psychology, part time, Harvard Medical School. He serves on the Board of Directors and faculty, Institute for Meditation and Psychotherapy and is author of The Mindfulness Solution: Everyday Practices for Everyday Problems, co-author of Sitting Together: Essential Skills for Mindfulness-Based Psychotherapy and Back Sense; and co-editor of Mindfulness and Psychotherapy and Wisdom and Compassion in Psychotherapy: Deepening Mindfulness in Clinical Practice. He is a long time student of mindfulness meditation and teaches internationally about the application of mindfulness practice in psychotherapy and other fields.

 

 

Roger Weiss, MD

 

Alcohol and Substance Abuse Treatment

 

Roger Weiss, MD is a Professor of Psychiatry at Harvard Medical School and Chief of the Division of Alcohol and Drug Abuse at McLean Hospital. He is the author over 300 scientific publications including, Integrated Group Therapy for Bipolar Disorder and Substance Abuse. Dr. Weiss is on the editorial board of many journals including American Journal of Drug and Alcohol Abuse and Journal of Clinical Psychiatry, and the American Journal on Addiction.